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免疫機能制御部門（客員部門）
客員教授 徐 5虫 （薬学博士）
本部門では，肝炎の発症と慢性化進行における免疫学的機序を細胞及び分子レベルてゆ解明し，和漢薬を含
む種々の資源から新しい肝炎治療薬の発見などを目的として研究を行っている。すでに肝炎の細胞性免疫
病理過程を動物にて模擬し，遅延型アレルギ一反応による新しい肝障害モデルの作成に成功した。また，こ
の肝障害の慢性化持続および薬効評価モデルとしての有用性などを証明した。その上でこの肝障害におけ
る分子機構，とくに細胞接着およびサイトカインの役割などについて研究を試みており，これらに対する和
漢生薬の作用およびその活性物質についても研究を続けている。本年度の主な研究課題と成果は下記のと
おりである。
I.肝障害の発症と進行に関する基礎的研究
1）マウスにて遅延型アレルギ一反応による新しい肝障害モデルを作成し，そのeffectorcellのーっと
して Thy1.2+, L3T4+, Lyt 2 T細胞であることを証明した。
2）この肝障害の発症において，マウス牌りんぱ球（SPC）及び肝内nonparenchymalcell (NPC）表
面lymphocytefunction associated antigen 1 (LFA-1），ならびに parenchymalhepatocyte (HC) 
表面のintercellularadhesion molecule-I (ICAM-1）の発現は有意に増加することを見い出した。
3) HCをNPCまたは SPCとco-cultureすることにより，培養上清中に alaninetransaminase 
(ALT）のreleaseが認められ，この作用は anti-mouseLFA-1でNPCまたは SPCを， anti-mouse
ICAM-1でHCを前処置することによって，ほぽ完全に抑制された。生体の免疫細胞がLFA-1/
ICAM-1 interactionを介して肝細胞に障害を与えることを示唆した。
4) LFA-1 positive細胞のうち，とくに CD4+killer T細胞が肝細胞障害の惹起において重要な役割を
果たすことを明かにした。
I.肝障害に対する中薬土夜苓およびその成分astilbinの影響
1）土夜苓の水’性エキスが遅延型免疫反応性肝障害を有意に改善した。
2）土夜苓の水d性エキスおよびastilbinがNPCの肝細胞障害作用を有意に抑制した。
I.肝障害の発症と進行に関する基礎的研究
1-1.遅延型アレルギー反応による新しい肝障害モデ
ルの作成およびそのeffector細胞
Xu, Q., Wang R., Jiang J., Wu F., Lu J., Tan P.K., 
and Xu L. : Liver injury model in mice induced by a 
cellular immunologic mechanism -delayed -type 
hypersensitivity-induced liver injury to picryl chlo-
ride and phenotype of effector cel. Cel. Immunolリ
167 : 38-43, 1996. 
Liver injury was induced in BALE/ c mice by 
local delayed-type hypersensitivity (DTH) to picryl 
chloride (PCI) . Distinct changes of biochemical 
parameters were observed including the elevation of 
serum alanine and aspartate aminotransferases, 
increase of liver lipid peroxides, as well as decrease 
of sen江nalkaline phosphatase. Damage was con-
firmed by histopathological findings such as he-
patocellular necrosis, granulocyte infiltration, and 
fatty degeneration. The liver injury was passively 
transferred into naive syngeneic mice by infusing 
spleen cells from immune mice. The capacity of出e
splenocytes to induce liver injury in recipient mice 
was almost completely abolished by pretreatment 
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of the cells with anti-Thy 1.2 or anti-CD4, but not 
anti-CDS antibody. These findings suggest that the 
production of liver injury by a local DTH mecha-
nism is possible and the subpopulation of T cels, 
Thy 1.2+, L3T4+, and Lyt-2-cels, is at least one of 
the effector cells that mediate the injury. 
I -2.遅延型アレルギー性肝障害の発症における分
子機構
1) Increased expression of lymphocyte function-
associated antigen-1 (LFA-1) on liver nonparen-
chymal cells (NPC) and spleen cells (SPC) and 
intercellular adhesion molecule-1 (ICAM-1) on par-
enchymal hepatocytes (HC) is observed in PCl -
DTH liver injury mice. 
The cell-cell interaction is the key process in the 
regulation of a variety of immune inflammations. 
To investigate the involvement of LFA-1/ICAM-l 
pathway in the pathogenesis of PCl-DTH liver 
injury, we first determined the expressions of LFA-
1 on NPC and SPC and ICAM-1 on HC by flow 
cytometric analysis. PCl-DTH liver injury was in-
duced as follows. Briefly, mice were sensitized 
twice by painting 0.1 ml of 1 % PCl in ethanol on the 
skin of their abdomens at an interval of 5 days. Five 
days after the second sensitization, they were inject-
ed with 10 μl of 0.2 % PCl in olive oil into the liver 
to elicit the liver injury, followed 0 (liver injury non-
elicited), 6, 12, 18 and 24 hr later by isolating the 
liver cells and spleen cels. The expression of LF A-
1 antigen on SPC tended to be increased in the PCl-
sensitized but liver injury non-elicited mice (0 hr) 
and rapidly reached a peak 6 hr after the PCl elicit-
ing. The expressions of LF A-1 on NPC and ICAM-
1 on HC reached a peak 12 hr after the eliciting. 
After the peak, the expressions of both LFA-1 and 
ICAM-1 were reduced and maintained in a level 
slightly higher than on 0 hr. The serum ALT activ-
ity significantly elevated at 12 hr and reached a 
peak at 18 hr after the challenge. These findings 
indicate that the increased expression in LF A 1 on
SPC and NPC as well as in ICAM-1 on HC may be 
linked to the production of liver injury. 
2) PCl DTH liver injury is reduced by 
splenectomy before eliciting. 
Mice were done splenectomy 12 hr before the PCl 
eliciting in liver. A remarkable elevation of serum 
ALT activity was observed in the sham-operated 
control mice. To the control, a significant decrease 
in ALT was found in the splenectomy group. In this 
case, the ICAM-1 expression on HC tended to be 
decreased in the splenectomy mice against control 
while no influence was observed in LF A-1 expres-
sion on NPC. 
3) Both NPC and SPC are in vitro cytotoxic 
against HC isolated from same mouse with PCl-
DTH liver injury. 
NPC and SPC were isolated from normal and PCl 
DTH liver injury mice 12 hr after PCl eliciting. One 
hundred thousands of HC were pre-incubated for 5 
hr and co-cultured with 4×105 and 1×106 of NPC or 
5×106 of SPC for further 3 and 15 hr, respectively. 
As compared with the controls that were added 
with the corresponding amounts of NPC or SPC 
from normal mice, the co-culture with either NPC 
or SPC obtained from the liver injury mice caused a 
remarkable elevation of ALT and AST in the cul司
ture supernatant. There was in general no distinct 
difference in such elevation between 3 and 15 hr co-
culture. The culture of NPC alone was also made 
and no detectable ALT activity was found in the 
supernatant. These results suggest that both SPC 
and NPC obtained from the liver injury mice show 
a direct cytotoxic activity to HC. 
Additionally, neither NPC nor SPC from liver 
injury non elicited mice caused the ALT release 
from HC. The ALT release from HC was shown by 
NPC obtained at 6 hr and reached a peak at 12 hr 
and declined at 18 and 24 hr after the eliciting. In the 
case of SPC, the release reached a peak 6 hr and 
was maintained in an almost same level 12 hr after. 
These changes in cytotoxic activity by NPC and 
SPC against HC seemed to be quite in accord with 
those in LF A 1 expression. 
4) Binding to LFA-1 of anti-LFA-1, or to ICAM 
1 molecule of anti-ICAM-1 before the co-culture 
abolishes the cytotoxic action of NPC and SPC to 
HC. 
To assay the role of LFA-1/ICAお1:-1interaction 
in the production of liver cel damage, NPC and 
SPC from PCl -DTH liver injury mice were 
pretreated with anti LF A 1 antibody to bind the 
LFA-1 molecules on the cel surface. To the he-
patocytes from liver injury mice, 4×105 NPC 
caused an ALT release in a same extent with S×106 
SPC. Such ability of NPC and SPC to release ALT 
was completely inhibited by the pretreatment with 
anti-LFA I. When the co-culture was conducted 
using the anti -ICAM l antibody prebound HC, 
cytotoxicity was observed by neither NPC nor SPC. 
To normal hepatocytes, only a weak cytotoxicity 
was observed by NPC and SPC from liver injury 
mice and inhibited by the pretreatment with anti-
LFA-1. 
5) CD4 positive T cells cause the hepatocyte 
damage through LF A-l/ICAM-1 interaction. 
NPC from liver injury mice was treated with 
various monoclonal antibodies before the co-culture 
with HC. The treatment by anti Thy 1.2, CD4 and 
LF A l antibodies plus complement almost com-
pletely abolished the cytotoxicity of NPC to HC. 
The anti CDS and anti Mac l antibody plus comple-
ment showed a tendency of inhibition. However, the 
treatment by these monoclonal antibodies without 
complement did not affect the cytotoxic action of 
NPC except for using anti LF A 1 antibody. 
Above results shown in 1)-5) suggest that the 
interaction between LF A-1 and ICAM-1 molecules 
is one of the important pathways in the pathoge 
nesis of liver injury induced by PCトDTH.The liver 
injury process may be supposed including the trig-
gering by PCl challenge in the liver for increasing 
the expression of these molecules, the infiltration to 
liver of lymphoytes containing LF A 1 positive cells 
from the peripheral lymph organs, the cel -cell 
adhesion between the infiltrated cells and he-
patocytes by LF A 1 IICAM 1 binding, and the 
cytotoxic action against parenchymal hepatocytes 
by the infiltrated cells mainly including CD4+ killer 
T cels. 
II.肝障害に対する中薬土夜苓およびその成分
astilbinの影響
The aqueous extract from Rhizoma Smilacis 
Glabrae (RSG) , which has been evidenced to selec-
tively inhibit the effector phase of PCl induced ear 
dermatitis and other DTH reactions, showed a 
remarkable improvement of liver injury in this 
model when given po for 3 times 0, 5 and 10 hr after 
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the PCl challenge in the liver. To investigate its 
mechanisms, the extract and its principle, astilbin 
have been used in the cell culture assay. As the 
result, neither the extract nor astilbin itself showed 
any cytotoxic activity to the isolated liver NPC or 
HC, but the pretreatment of NPC with either of 
them remarkably blocked the toxic action to HC. 
These results suggest that RSG and astilbin may 
improve the immunological liver injury through 
affecting the function of immune effector cels. 
学会報告
1 ) Xu Q., Wu F., Lu J., and Jiang J. : Chronic 
development of delayed←type hypersensitivity in-
duced liver injury to picryl chloride and effect of 
some drugs on it. The fourth Japan China joint 
meeting on pharmacology, 1996, 10, p.48, Fukuoka. 
The chronic development of liver injury induced 
by delayed type hypersensitivity to picryl chloride 
(PCトDTH)was observed in mice for over 9 weeks 
accompanying with the changes in various biochem司
ical, immunological and histopathological parame-
ters. Some of those were characteristic and signifi-
cant such as the marked elevation of lactic dehy-
drogenase (LDH) activity in serum and hydroxy-
proline (Hyp) content in liver, and the dramatic 
decrease of alkaline phosphatase (AP) level in 
serum. Such changes could be exasperated by the 
systemic transfer of spleen cells from mice that 
were in the acute phase of liver injury but improved 
by that in the chronic phase of liver injury, paral-
leled with the phenotypic changes of T lymphocytes. 
At the same time, the hepatocyte regeneration, 
Kupffer’s cell proliferation, connective tissue hyper-
plasia and bridging necrosis were observed remark-
ably. To the chronic development, glycyrrhizin, 
malotilate and PSK significantly recovered both 
declining of AP activity and increasing of LDH 
activity and Hyp content. The improvement of liver 
injury was also made by the Chinese herbal drugs, 
RhizomαSmit,αcis Glabγae and Coγtex Dietαmni, 
Which showed a selective inhibition on the effector 
phase of DTH reactions. These results suggest that 
PCl DTH liver injury could develop to a chronic 
state and T lymphocyte functions may be important 
for the development. Regulation on the cellular 
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immune functions such as DTH reaction may be one 
of the ways for developing a novel drug for hepati-
tis. 
2) Qiang Xu : Therapy for hepatitis by traditional 
Chinese Medicine and new attempt for developing 
drugs. The 5th International Symposium on Tradi-
tional Medicine. 1996, 1, p.3, 175 181. Toyama. 
There remains lack of the special treatment and 
effective drugs for chronic hepatitis so far. In China, 
this kind of disease is usually treated by a combined 
therapy including Traditionai Chinese Medicine 
(TCM). The therapeutic principles are generally 
selected in the case by TCM named as Qing-Re-J ie-
Du, H uo -Xue -Hua -Yu, Fu -Zheng-Gu Ben, etc. 
Many traditional Chinese medicines including the 
formulations that accord with the principles have 
been evidenced to be effective on the symptoms of 
hepatitis and some of them are also capable of 
promoting the negative conversion in HBV antigen 
positive patients. It could be said, therefore, that 
TCM plays an important role in the treatment of 
clinical chronic hepatitis in China. On the other 
hand, an ideal animal model of liver injury is needed 
for elucidating the pathogenesis of hepatitis and for 
developing new drugs. For this reason, we have 
established a new liver injury model induced in mice 
by a typical cellular immune response, delayed type 
hypersensitivity to picryl chloride and clarified the 
effector cells involved in the model. Interestingly, 
the liver injury was found to be sustained for over 9 
weeks and the biochemical, immunological and 
histopathological features in the chronic develop-
ment were examined comprehensively. Further-
more, observations using various drugs for hepatitis 
also suggested that this model may be useful for the 
pharmacological study. By the model, some herbal 
drugs and their principles such as Fructus Triburi, 
Rαdix G開 ti，α悦侃， RhizomαSmit,αcisGlabγαe, Coγtex 
Dictamni and Ruscogenoside C from the radix of 
Liriope muscari were proved to be effective on the 
liver injury. The cooperation effects were also 
observed between some of the drugs. Further inves-
tigations on the effective mechanisms of these 
herbal drugs as well as their effective components 
may help the development of more effective strat-
egies and novel drugs for the treatment of the insidi-
ous disease. 
その他
1 ）徐強：漢方理論の近代科学認識と動物モデルに
よる薬効評価．富山漢方会， 1996,12, 20，富山．
